cisapride has been researched along with levodopa in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
de Yebenes, JG; Mena, MA; Neira, WD; Sanchez, V | 1 |
Achiron, A; Djaldetti, R; Koren, M; Melamed, E; Ziv, I | 1 |
Djaldetti, R; Melamed, E; Ziv, I | 1 |
1 review(s) available for cisapride and levodopa
Article | Year |
---|---|
Impaired absorption of oral levodopa: a major cause for response fluctuations in Parkinson's disease.
Topics: Administration, Oral; Antiparkinson Agents; Cisapride; Drug Therapy, Combination; Gastric Emptying; Humans; Injections, Intramuscular; Intestinal Absorption; Levodopa; Parasympathomimetics; Parkinson Disease; Piperidines | 1996 |
1 trial(s) available for cisapride and levodopa
Article | Year |
---|---|
Effect of cisapride on response fluctuations in Parkinson's disease.
Topics: Aged; Cisapride; Drug Therapy, Combination; Gastric Emptying; Humans; Levodopa; Middle Aged; Motor Activity; Parkinson Disease; Piperidines; Reaction Time | 1995 |
6 other study(ies) available for cisapride and levodopa
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
The effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease.
Topics: Aged; Cisapride; Female; Gait; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Piperidines; Psychomotor Performance | 1995 |